This content is from: Patents

Associations call for Section 101 overhaul in comments to USPTO

PhRMA, ABA and AIPLA have submitted comments to the USPTO, and IPO has passed a resolution, all urging legislative changes to Section 101

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial